SK-BR-3 Xenografts

 

Rincon Bio performs SK-BR-3 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Breast

Organism: Homo sapiens, human  /  Tissue: mammary gland/breast; derived from metastatic site: pleural effusion  /  Disease: adenocarcinoma

Notes

This cell line was derived by G. Trempe and L. J. Old in 1970 from pleural effusion cells of a patient, a White, Caucasian female, age 43, blood type A+, who had been treated with radiation, steroids, cytoxan and 5-fluorouracil. Ref

in vivo

Forms tumors in nude mice

Used in xenografts to test the efficacy of novel cancer therapeutics 

Request Quote

Receive a quote within one business day for a SK-BR-3  xenograft

Rincon Bio Growth Curve

SK-BR-3 Xenograft.png

Cell Line: SK-BR-3

Mouse Strain: Nude

Matrigel: Yes

Cells Implanted per Animal: 5 million

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are easy to work with.  And we take a personal interest in our clients and their studies.